Morbius was not well received by the majority of critics (it currently sits at an abysmal 17% on Rotten Tomatoes), but even with a C+ CinemaScore, the Sony Pictures Marvel movie has had a moderately successful opening weekend.
The Living Vampire's big-screen debut is expected to take the #1 spot at the domestic box office with an estimated $38M - $41M from 4,268 locations. While this is nowhere close to the studio's previous SPUMC films' takings (Venom and Venom: Let There Be Carnage made $80.2M and $90M, respectively), it is more than the studio's predicted $33M, and with a reported budget of $75M, the movie still stands a chance of turning a (small) profit.
Of course, that will be dependant on a lot of factors, and poor word-of-mouth could well lead to a significant second-week drop-off. Then again, a 69% audience score on RT does suggest that cinemagoers haven't been nearly as hard on Morbius as critics, so it might end up surprising us.
In related BO news, Warner Bros.' The Batman has continued to pack 'em in worldwide. Matt Reeves' acclaimed reboot took in another $3.1 million on Friday, bringing its domestic cume to $341.3 million. This brings The Dark Knight's latest solo outing past the $700M mark globally.
Have you been to see Morbius yet? Do you plan to, or have the reviews put you off? Be sure to let us know in the comments section.
About The Author:
Mark Cassidy is a writer, photographer, amateur filmmaker, and Rotten Tomatoes-approved critic from Dublin, Ireland.